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Abstract
A genetic association of the ENPP1 gene with primary hand
osteoarthritis was recently reported in this journal. ENPP1
encodes an enzyme that regulates soft tissue calcification. The
study as it stands is far from complete because the actual causal
variant(s) within ENPP1 has not been identified and no functional
study on the activity of the enzyme in hand osteoarthritis was
presented. Nevertheless, the study stimulates interest and will
encourage others in the field to test ENPP1 as a possible
osteoarthritis susceptibility gene in their cohorts. The genetic basis
of osteoarthritis is slowly being uncovered, and this report
constitutes another interesting find.
Crystal deposition is often observed in osteoarthritic joints
but its role as a causative agent in the disease is unclear. Suk
and coworkers [1] have taken a genetic approach to
answering this question by determining whether common
DNA variants in the gene encoding the enzyme ecto-
nucleotide pyrophosphatase phosphodiesterase (ENPP)1 are
associated with osteoarthritis of the hand. ENPP1 generates
inorganic pyrophosphate (PPi) from nucleoside triphos-
phates, which acts as an inhibitor of hydroxyapatite and there-
fore prevents soft tissue calcification. Suk and colleagues
were stimulated to investigate common polymorphisms in the
ENPP1 gene following their previous genetic investigation of
the rare Mendelian condition generalized arterial calcification
of infancy. This disease is characterized by calcification of the
arteries, but many patients also exhibit periarticular
calcifications and inflammation [2]. Suk and coworkers
therefore hypothesized that common variants in ENPP1 may
be risk factors for common osteoarthritis.
To answer this question the investigators initially carried out a
radiographic examination of the hands of 574 adults from
126 pedigrees derived from a relatively isolated population of
Chuvashians from southern Russia. Hand osteoarthritis status
was then determined using the Kellgren-Lawrence scale.
DNA from each patient was subsequently genotyped for
three short tandem repeat polymorphisms (also known as
microsatellites) and for four common single nucleotide
polymorphisms, two of which encode amino acid substitu-
tions (nonsynonymous single nucleotide polymorphisms). The
seven variants provided physical coverage of the whole gene.
The genotype data were then tested for association with
osteoarthritis using the transmission disequilibrium test. This
is a neat statistical method for testing associations that uses
internal controls and therefore avoids the potential pitfall of
inadequately matched controls that can lead to false-positive
results in case-control association studies.
The transmission disequilibrium test analysis revealed a
number of associations when the individual variants were
tested and when the genotype data from several variants
were examined in combination in a haplotype analysis. The
most compelling results were obtained for a short tandem
repeat located immediately upstream of ENPP1. This is an
intriguing find because it implies that susceptibility to hand
osteoarthritis may be encoded by polymorphism in cis
elements that regulate the expression of ENPP1, rather than
in DNA changes that lead to amino acid substitution in the
protein. It is becoming increasingly apparent that poly-
morphism in the regulation of gene expression is common
and that this can have a significant influence on the develop-
ment of complex diseases [3,4]. To determine whether poly-
morphism in cis regulatory elements of ENPP1 occurs, Suk
and colleagues should be encouraged to test the gene for
differences in expression at the allelic level.
Suk and coworkers [1] conducted their study on an isolated
population of Chuvashians. To assess the global relevance of
their find it will be necessary to test the association in cohorts
derived from different ethnic groups. Two centres have
recently reported genome-wide linkage scans for hand
osteoarthritis; the Framingham study in the USA and DeCode
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chromosome 6q23.2, which is the position of ENPP1.
However, linkage scans can miss loci of weak to moderate
effect, and it would be desirable if these two centres
examined ENPP1 in their cohorts. To assess the relevance of
ENPP1 to osteoarthritis development at sites other than the
hand, the ENPP1 variants should be genotyped in patients
with severe disease at the hip, knee, or spine. The
osteoarthritis research community is relatively fortunate in that
many groups have collected OA cohorts suitable for genetic
analyses [6], making confirmatory studies feasible.
The genetic investigation of osteoarthritis has had a fillip in
recent years, with compelling associations reported to
several genes, including FRZB,  ASPN,  CALM1  and the
interleukin-1 gene cluster [5,7]. This latest result reported by
Suk and coworkers [1] is another interesting find. However,
before we get carried away it is essential that the actual
causal variant(s) at ENPP1 be identified and substantiated
with compelling functional tests. These are difficult but
essential goals.
Conclusion
Finally, it is interesting to dwell a little on recent genetic finds.
The genes so far identified encode proteins that have a
diverse range of normal physiological roles, from regulating
the expression of extracellular matrix structural protein genes
through to regulating a number of cartilage anabolic and
catabolic factors. As many have expected, it appears that
there are several paths that can lead toward the development
of osteoarthritis. ENPP1 and its regulation of PPi and
calcification may be highlighting another.
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